Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. Macrophages are present in the living ecosystem of many types of cancer. Using digital imaging, bioinformatics, and machine learning techniques, research led by N2CR member, Dr Anand Jeyasekharan, discovered 6 different macrophage signatures (MacroSigs) that can help distinguish types of macrophages in normal lymph nodes and diffuse large B-cell lymphoma (DLBCL), a tumour arising from our lymph nodes. This groundbreaking discovery helps doctors understand the evolution of this disease and how some DLBCL tumours relapse after chemotherapy. 

Read more: https://www.nature.com/articles/s41467-024-46220-z

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →